All News

2019

October

Media Release / Oct 16, 2019

Novartis announces that Jakavi® (ruxolitinib) meets primary endpoint in Phase III study of acute graft-versus-host disease

Read More
Featured News / Oct 11, 2019

Pride @ Novartis 2019

As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.

Read More
Female patient having an eye examination
Featured News / Oct 10, 2019

World Sight Day 2019

Read More
Media Release / Oct 10, 2019

Novartis data show Cosentyx® treatment results in rapid and sustained resolution of signs and symptoms of psoriatic arthritis in patients with and without enthesitis

Read More
Media Release / Oct 09, 2019

Novartis real-world evidence confirms high efficacy, long-term response and favorable safety profile of Cosentyx® in clinical practice

Read More
Christine Hà, blind chef, shares advice on navigating the world as a visually impaired entrepreneur.
Story / Oct 08, 2019

Lessons from a blind chef

Christine Hà lost her vision at a young age – and went on to become an award-winning chef.

Read More
Media Release / Oct 08, 2019

Novartis data show more patients are completely symptom-free from chronic spontaneous urticaria with ligelizumab (QGE031) than Xolair® 300 mg

Read More
Media Release / Oct 08, 2019

Novartis receives FDA approval for Beovu®, offering wet AMD patients vision gains and greater fluid reductions vs aflibercept

Read More
Media Release / Oct 05, 2019

AveXis presents updated STRONG data at WMS

Read More
Lauren Abrey and her two daughters posing in front of a city.
Story / Oct 03, 2019

Women in Science: Lauren Abrey

Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.

Read More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More